Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)
International Journal of Neonatal Screening · 23.05.2024 · 10 (2) · 38
DOI: 10.3390/ijns10020038 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 23.05.2024. Verfasst von Bradford L Therrell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA. Die Arbeit wurde bisher 173-mal zitiert (Crossref) und nennt 1590 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Newborn bloodspot screening (NBS) began in the early 1960s based on the work of Dr. Robert “Bob” Guthrie in Buffalo, NY, USA. His development of a screening test for phenylketonuria on blood absorbed onto a special filter paper and transported to a remote testing laboratory began it all. Expansion of NBS to large numbers of asymptomatic congenital conditions flourishes in many settings while it has not yet been realized in others. The need for NBS as an efficient and effective public health prevention strategy that contributes to lowered morbidity and mortality wherever it is sustained is well known in the medical field but not necessarily by political policy makers. Acknowledging the value of national NBS reports published in 2007, the authors collaborated to create a worldwide NBS update in 2015. In a continuing attempt to review the progress of NBS globally, and to move towards a more harmonized and equitable screening system, we have updated our 2015 report with information available at the beginning of 2024. Reports on sub-Saharan Africa and the Caribbean, missing in 2015, have been included. Tables popular in the previous report have been updated with an eye towards harmonized comparisons. To emphasize areas needing attention globally, we have used regional tables containing similar listings of conditions screened, numbers of screening laboratories, and time at which specimen collection is recommended. Discussions are limited to bloodspot screening.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA.
- National Newborn Screening and Global Resource Center, Austin, TX 78759, USA.
- Department of Pediatrics, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines.
- Detección de Errores Congénitos-Fundación Bioquímica Argentina, La Plata 1908, Argentina.
- Jacques LOISELET Genetic and Genomic Medical Center, Faculty of Medicine, Saint Joseph University, Beirut 1104 2020, Lebanon.
- Office of the International Society for Neonatal Screening, Reigerskamp 273, 3607 HP Maarssen, The Netherlands.
ORCID-Profile: Bradford L Therrell, Carmencita D Padilla, Gustavo J C Borrajo, Issam Khneisser, Peter C J I Schielen, Helen L Malherbe
Zitieren
APA
Therrell, B. L., Padilla, C. D., Borrajo, G. J. C., Khneisser, I., Schielen, P. C. J. I., Knight-Madden, J., Malherbe, H. L., & Kase, M. (2024). Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023). International Journal of Neonatal Screening, 10(2), 38. https://doi.org/10.3390/ijns10020038
Vancouver
Therrell BL, Padilla CD, Borrajo GJC, Khneisser I, Schielen PCJI, Knight-Madden J, et al. Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023). International Journal of Neonatal Screening. 2024;10(2):38. doi:10.3390/ijns10020038
BibTeX
@article{Therrell2024,
author = {Therrell, Bradford L and Padilla, Carmencita D and Borrajo, Gustavo J C and Khneisser, Issam and Schielen, Peter C J I and Knight-Madden, Jennifer and Malherbe, Helen L and Kase, Marika},
title = {Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)},
journal = {International Journal of Neonatal Screening},
year = {2024},
volume = {10},
number = {2},
pages = {38},
doi = {10.3390/ijns10020038}
}
EUVIMED